Atrial Fibrillation Community Talk
Hybrid ablation and the minimally invasive Cox Maze procedures revolutionize the way we treat Atrial Fibrillation
Atrial fibrillation (AFib) is the most common irregular heart rhythm, affecting over two million Americans each year. Without detection and treatment, atrial fibrillation can cause stroke and heart failure
Stanford Medicine experts are pioneering new treatments for AFib, through medications and groundbreaking new therapies like the hybrid ablation or the minimally invasive Cox Maze procedure. Join us for this free community talk to learn more about AFib’s signs, symptoms, and all of the latest advances in treatment.
Paul J. Wang, MD
Director, Stanford Arrhythmia Service Co-Director, Stanford Center for Arrhythmia Research Professor of Medicine (Cardiovascular Medicine) and Bioengineering (by courtesy), Stanford University School of Medicine
Anson M. Lee, MD
Assistant Professor of Cardiothoracic Surgery (Adult Cardiac Surgery), Stanford University School of Medicine